SITO Mobile to Present at the Spring 2016 Sidoti Emerging Growth Convention
Mar 18, 2016 12:00 pm UTC| Business
JERSEY CITY, N.J., March 18, 2016 -- SITO Mobile Ltd. (Nasdaq:SITO), a leading mobile engagement platform provider, announced today that Jerry Hug, SITO’s CEO, will be presenting on behalf of the company at the 2016...
Mar 18, 2016 12:00 pm UTC| Business
DURHAM, N.C., March 18, 2016 -- Argos Therapeutics, Inc. (Nasdaq:ARGS) (“Argos”), an immuno-oncology company focused on the development and commercialization of truly individualized immunotherapies for the treatment of...
Mar 18, 2016 11:50 am UTC| Business
Dublin, March 18, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/ntlcwx/micro_packaging) has announced the addition of the "Micro Packaging - An Evolving Packaging Technology" ...
Surgery Partners Announces Proposed $400 Million Senior Note Offering
Mar 18, 2016 11:45 am UTC| Business
NASHVILLE, Tenn., March 18, 2016 -- Surgery Partners, Inc. (NASDAQ:SGRY) today announced that its wholly-owned subsidiary, Surgery Center Holdings, Inc. (collectively, “Surgery Partners”), intends to commence a private...
Mar 18, 2016 11:40 am UTC| Business
Dublin, March 18, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/x8pdwt/global_laboratory) has announced the addition of the "Global Laboratory Cart Market 2016-2020" report to...
Cidara Reports Fourth Quarter and Full Year 2015 Financial Results and Provides Corporate Update
Mar 18, 2016 11:30 am UTC| Business
SAN DIEGO, March 18, 2016 -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other infections, today reported financial results...
MyoKardia Reports Fourth Quarter and 2015 Financial Results and Key Milestones
Mar 18, 2016 11:30 am UTC| Business
- Lead product candidate demonstrates clinical proof of mechanism in hypertrophic cardiomyopathy (HCM) patients; Phase 2 planned for second half of 2016 - Growing evidence in nonclinical studies that MYK-461 reduces left...